拓斯達(300607.SZ):持續推進全電動注塑機以及控制器、伺服驅動等相關核心零部件的研發
格隆匯3月9日丨拓斯達(300607.SZ)在接受特定對象調研時表示,2022年公司在注塑機板塊重心在於“打磨產品”,2023年公司將會把該業務重心逐漸向“提升規模”轉變,通過提升銷售規模、優化供應鏈成本、平衡產能投入等方式,提高盈利能力。
同時,公司在持續推進全電動注塑機以及控制器、伺服驅動等相關核心零部件的研發,目前處於客户現場調試樣機階段,後續有望小批量逐步推出市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.